Prediction of Drug Pathway-based Disease Classes using Multiple Properties of Drugs

被引:10
作者
Chen, Lei [1 ]
Li, Linyang [1 ]
机构
[1] Shanghai Maritime Univ, Coll Informat Engn, Shanghai 201306, Peoples R China
关键词
Drug repositioning; drug classification; pathway; network; mashup; singular value decomposition; multi-label classification; MELANOCYTE-STIMULATING HORMONE; RANDOM-WALK; NETWORK; INTEGRATION; INFORMATION; NIZATIDINE; OLANZAPINE; RAPAMYCIN; PLASMA; LABEL;
D O I
10.2174/0115748936284973240105115444
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Background Drug repositioning now is an important research area in drug discovery as it can accelerate the procedures of discovering novel effects of existing drugs. However, it is challenging to screen out possible effects for given drugs. Designing computational methods are a quick and cheap way to complete this task. Most existing computational methods infer the relationships between drugs and diseases. The pathway-based disease classification reported in KEGG provides us a new way to investigate drug repositioning as such classification can be applied to drugs. A predicted class of a given drug suggests latent diseases it can treat.Objective The purpose of this study is to set up efficient multi-label classifiers to predict the classes of drugs.Methods We adopt three types of drug information to generate drug features, including drug pathway information, label information and drug network. For the first two types, drugs are first encoded into binary vectors, which are further processed by singular value decomposition. For the third type, the network embedding algorithm, Mashup, is employed to yield drug features. Above features are combined and fed into RAndom k-labELsets (RAKEL) to construct multi-label classifiers, where support vector machine is selected as the base classification algorithm.Results The ten-fold cross-validation results show that the classifiers provide high performance with accuracy higher than 0.95 and absolute true higher than 0.92. The case study indicates the novel effects of three drugs, i.e., they may treat new diseases.Conclusion The proposed classifiers have high performance and are superiority to the classifiers with other classic algorithms and drug information. Furthermore, they have the ability to discover new effects of drugs.
引用
收藏
页码:859 / 872
页数:14
相关论文
共 59 条
[31]   α-Melanocyte-stimulating hormone is decreased in plasma of patients with acute brain injury [J].
Magnoni, S ;
Stocchetti, N ;
Colombo, G ;
Carlin, A ;
Colombo, A ;
Lipton, JM ;
Catania, A .
JOURNAL OF NEUROTRAUMA, 2003, 20 (03) :251-260
[32]   Weight gain management in patients with schizophrenia during treatment with olanzapine in association with nizatidine [J].
Marques Assuncao, Sheila Seleri ;
Ruschel, Sandra Ines ;
Rodrigues Rosa, Lucena de Cassia ;
O Campos, Joo Alberto ;
O Alves, Mercedes Jurema ;
Bracco, Oswaldo Luis ;
de Lima, Mauricio Silva .
REVISTA BRASILEIRA DE PSIQUIATRIA, 2006, 28 (04) :270-276
[33]   Drug repositioning: a machine-learning approach through data integration [J].
Napolitano, Francesco ;
Zhao, Yan ;
Moreira, Vania M. ;
Tagliaferri, Roberto ;
Kere, Juha ;
D'Amato, Mauro ;
Greco, Dario .
JOURNAL OF CHEMINFORMATICS, 2013, 5
[34]   KEGG: Kyoto Encyclopedia of Genes and Genomes [J].
Ogata, H ;
Goto, S ;
Sato, K ;
Fujibuchi, W ;
Bono, H ;
Kanehisa, M .
NUCLEIC ACIDS RESEARCH, 1999, 27 (01) :29-34
[35]   New Perspectives on How to Discover Drugs from Herbal Medicines: CAM's Outstanding Contribution to Modern Therapeutics [J].
Pan, Si-Yuan ;
Zhou, Shu-Feng ;
Gao, Si-Hua ;
Yu, Zhi-Ling ;
Zhang, Shuo-Feng ;
Tang, Min-Ke ;
Sun, Jian-Ning ;
Ma, Dik-Lung ;
Han, Yi-Fan ;
Fong, Wang-Fun ;
Ko, Kam-Ming .
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2013, 2013
[36]   DeepWalk: Online Learning of Social Representations [J].
Perozzi, Bryan ;
Al-Rfou, Rami ;
Skiena, Steven .
PROCEEDINGS OF THE 20TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING (KDD'14), 2014, :701-710
[37]  
Peters T, 2014, Skin Therapy Lett, V19, P1
[38]   Drug repurposing: progress, challenges and recommendations [J].
Pushpakom, Sudeep ;
Iorio, Francesco ;
Eyers, Patrick A. ;
Escott, K. Jane ;
Hopper, Shirley ;
Wells, Andrew ;
Doig, Andrew ;
Guilliams, Tim ;
Latimer, Joanna ;
McNamee, Christine ;
Norris, Alan ;
Sanseau, Philippe ;
Cavalla, David ;
Pirmohamed, Munir .
NATURE REVIEWS DRUG DISCOVERY, 2019, 18 (01) :41-58
[39]   Extended-Connectivity Fingerprints [J].
Rogers, David ;
Hahn, Mathew .
JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2010, 50 (05) :742-754
[40]   A feasibility and safety study of afamelanotide in acute stroke patients - an open label, proof of concept, phase iia clinical trial [J].
Stanislaus, Vimal ;
Kam, Anthony ;
Murphy, Lily ;
Wolgen, Philippe ;
Walker, Gill ;
Bilbao, Pilar ;
Cloud, Geoffrey C. .
BMC NEUROLOGY, 2023, 23 (01)